Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects

Clinical trial NCT05344729 · COMPLETED

Trial details

NCT number: NCT05344729
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent/Metastatic Breast Cancer

Start date: 2021-07-06
Primary completion: 2021-08-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.